Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides;Langzeitergebnisse der ganzhautelektronenbestrahlung (GET) in der therapie der mycosis fungoides

Hautarzt

Volumn 54, Issue 3, 2003, Pages 256-264

  Hagedorn, M ^a   Hasche, E ^a   Kober, B ^a   Sander, C A ^b  

^a KLINIKUM DARMSTADT   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Mycosis fungoides; Therapy; Total skin electron beam therapy

Indexed keywords

ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER GRADING; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; ELECTRON BEAM; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LONG TERM CARE; MALE; MYCOSIS FUNGOIDES; OUTCOMES RESEARCH; PUVA; RADIATION DOSE; REMISSION; T CELL LYMPHOMA; TECHNIQUE; TOTAL SKIN ELECTRON THERAPY; TREATMENT FAILURE; TREATMENT INDICATION;

ADULT; AGED; ELECTRONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RETREATMENT; SKIN; SKIN NEOPLASMS; WHOLE-BODY IRRADIATION;

EID: 0037862920     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Christ G (1987) Physical aspects of total-skin-irradiation. Strahlenther Onkol 163;266-267
2. Fischer T, van Vloten WA, Volden G (1978) Internal dissemination of mycosis fungoides despite successful local therapy. Acta Derm Venerol 58:88
3. Hagedorn M, Slanina J, Kuphal K, Wenning J (1986) Behandlung einer symptomatischen Mucinosis follicularis bei Mycosis fungoides mit schnellen Elektronen. Hautarzt 37:667-672
4. Herbst M, Müller R (1984) Ganz-Haut-Elektronentherapie der Mycosis fungoides und des Sézary-Syndroms. Hautarzt 35:16-21
5. Hoppe RT, Woode GS, Abel EA (1990) Mycosis fungoides and the Sézary syndrome: pathology, staging and treatment. Curr Prob Cancer 14:297-361
6. Hoppe RT (1991) Total skin electron beam therapy in the management of mycosis fungoides. In: Veath JM, MeyerJL (eds) The role of high energy electrons in the treatment of cancer. Frontiers in Radiation Therapy and Oncology 25:80-89
7. Hoppe RT, Cox RS, Fuks Z, Price NM, Bagshaw MA, Farber EM (1979) Electronbeam therapy for mycosis fungoides: the Stanford University experience. Cancer Treat Rep 63:691-700
8. International Commission on Radiation Units and Measurements (1984) ICRU Report 35. Bethesda, M:61-61
9. Jaffe ES, Harris NL, Stein H, Vardiman J (2001) Pathology and genetics of tumours of haematopoetic and lymphoid tissues. Lyon, France, IARC Press
10. Jones GW, Mc Lean J, Rosenthal D, Roberts J, Suader DN (1992) Combined Treatment with oral etretinate and electron beam therapy in patients with cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome) J Am Acad Dermatol 26:960-967
11. Jones GW, Tadros A, Hodson DI, Rosenthal D, Roberts J, Thorson B (1994) Prognosis with diagnosed Mycosis fungoides after total skin electron radiation of 30 or 35 Gy. Int J Radiation Oncology Biol Phys 28:839-845
12. Jones GW, Hoppe T, Glatstein E (1995) Electron beam treatment for cutaneous T-cell lymphoma. Haematol Oncol Clinics North Am 9:1057-1076
13. Kaudewitz P, Sander CA, Flaig MJ (2000) Kutane Lymphome. In: Emmerich B (Hrsg) Manual Maligne Lymphome, 6. Aufl. Zuckschwerdt, München, S 146-155
14. Kim YH, Chow S, Varghese A, Hoppe RT (1999) Clinical characteristics and long term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. Arch Dermatol 135:26-32
15. Kim YH, Jensen Ra, Watanabe GL, Varghese A, Hoppe RT (1996) Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis. Arch Dermatol 132:1309-1313
16. Le Bourgeois JP, Haddad E, Marinello G, Marin L, Mazeron JJ, Ganem G (1987) The indications for total cutaneous electron beam radiation therapy of mycosis fungoides. Int J Radiation Oncol Biol Phys 13:189-193
17. Minna JD, Roenigk HH Jr, Glatstein E (1979) Report of the committee on therapy for mycosis fungoides and Sézary syndrome. Cancer Treat Rep 63(4):729-736
18. Muche JM, Gellrich S, Sterry W (2000) Treatment of cutaneous T-cell lymphomas. Semin Cutan Med Drug 19:142-148
19. Müller-Sievers K, Schäffler D, Kober B, Wöllgens P (1988) Zur Dosierung im rotierenden Phantom bei Elektronen-Abstandsbestrahlung. Strahlenther Onkol 164:484-488
20. Quiros PA, Jones GW, Kacinski BM, Braverman IM, Heald PW, Edelson RL, Wilson LD (1997) Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet - a light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides). Int J Radio Oncol Biol Phys 38:1027-1035
21. Sander CA, Flaig MJ, Kaudewitz P, Jaffe ES (1999) The Revised European-American Classification of lymphoid Neoplasmas (REAL): a preferred approach for the classification of cutaneous lymphomas. Am J Dermatol 21:274-278
22. Scholtz W (1902) Über den Einfluss der Röntgenstrahlen auf die Haut in gesundem und kranken Zustande. Arch Dermatol Syphiligr 59:421-446
23. Siegel RS, Pandolfino T, Guitart J, Rosen S, Kuzel TM (2000) Primary cutaneous T-cell lymphoma: review and current concepts. J Clin Oncol 18:2908-2925
24. Slanina J, Kuphal K, Brugmoser G, Hagedorn M (1987) Total skin irradiation of mycosis fungoides using 5 MeV electrons and isocentric rotational beam technique. Strahlenther Onkol 163:278-279
25. Stadler R (2000) Behandlung kutaner T-Zell-Lymphome. In: Plettenberg A, Meigel WN, Moll I (Hrsg) Dermatologie an der Schwelle zum neuen Jahrtausend. Springer, Berlin Heidelberg New York Tokyo, S 470-473
26. Sterry W, Jahm S (1995) Kutane maligne Lymphome. Z Hautkr 70:781-788
27. Tourbier HU, Schultz-Ehrenburg U (1981) Etagenwechsel bei Mycosis fungoides unter systemischer PUVA-Therapie. Z Hautkr 56:923
28. Trump JG, van de Graaf RJ, Cloud RW (1940) Cathode rays for radiation therapy. Am J Roentgenol 43:728-734
29. Trump JG, Wright KA, Evans WW et al. (1953) High energy electrons for treatment of extensive superficial malignant lesions. Radiol Ther Nuclear Med 69:623-629
30. Van Scott EJ, Kalmanson JD (1973) Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitisation and by induction of specific immunologic tolerance. Cancer 32:18-30
31. Willemze R, Kerl H, Sterry W et al. (1997) EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood 90:354-371
32. Wilson LD, Quiros PA, Kolenik SA, Heald PW, Braverman IM, Edelson RL, Kacinski BM (1996) Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma. J Am Acad Dermatol 7:69-73